Your search returned 26 studies. (Get alerts for new studies):
- Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Conditions: Sepsis - Acute Lung Injury - Acute Respiratory Distress Syndrome
Location: Hazard, Kentucky
- Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Conditions: Pancreatic Cancer - Ductal Adrenocarcinoma - Exocrine Pancreatic Cancer
Location: Hazard, Kentucky
- PAVES: Pegfilgrastim Anti-VEGF Evaluation Study
Conditions: Cancer - Colon Cancer - Colorectal Cancer - Fever - Locally Advanced - Metastatic Colorectal Cancer - Neutropenia - Rectal Cancer
Location: Hazard, Kentucky
- Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
Conditions: Rosacea
Location: Corbin, Kentucky
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Corbin, Kentucky
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Corbin, Kentucky
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Hazard, Kentucky
- Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
Conditions: Follicular Lymphoma
Location: Hazard, Kentucky
- Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Conditions: Venous Thrombosis
Location: Hazard, Kentucky
- Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Conditions: Venous Thrombosis
Location: Hazard, Kentucky
- Study of Immunotherapy to Treat Advanced Prostate Cancer
Conditions: Prostate Cancer
Location: Hazard, Kentucky
- Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carbopla
Conditions: Lung Cancer - Non Small Cell
Location: Hazard, Kentucky
- Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma
Location: Hazard, Kentucky
- An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N Compared With Plasma for Rapid R
Conditions: Reversal of Coagulopathy
Location: Hazard, Kentucky
- A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
Conditions: Adenocarcinoma of the Lung
Location: Hazard, Kentucky
- Combining Lesinurad With Allopurinol in Inadequate Responders
Conditions: Gout
Location: Elizabethtown, Kentucky
- Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Conditions: Adenoviral Conjunctivitis
Location: Hazard, Kentucky
- Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
Location: Louisville, Kentucky
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Hazard, Kentucky
- Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breas
Conditions: Breast Cancer
Location: Hazard, Kentucky
- ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer (NSCLC)
Location: Hazard, Kentucky
- Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: New Tazewell, Tennessee
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Morristown, Tennessee
- A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Conditions: Overactive Bladder
Location: New Tazewell, Tennessee
- Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain
Conditions: Chronic Nonmalignant and Nonneuropathic Pain
Location: New Tazewell, Tennessee
- Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain
Conditions: Chronic Low Back Pain
Location: New Tazewell, Tennessee
|